
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp has demonstrated impressive organic revenue growth, achieving +12.3% year-over-year in 2023, followed by +7.7% in 2024 and +7.4% year-to-date in 2025, indicating resilience and effective management in its personal care segment. The recent 2.6% Medicare Hospice rate increase set to take effect in 2025 is expected to further enhance revenue streams, particularly in the key hospice segment, which is transitioning to a stable growth state. Additionally, anticipated mergers and acquisitions, along with local operational enhancements, position the company favorably for continued revenue expansion in the near term.
Bears say
Addus HomeCare has faced significant challenges in 2025, notably experiencing same-store declines driven primarily by the ongoing impacts of Medicaid redeterminations, which have created administrative bottlenecks that hinder patient onboarding and lead to higher discharge rates compared to new admissions. Around 97% of its segment revenues are tied to Medicaid, generating considerable uncertainty regarding future funding due to legislative changes like the One Big Beautiful Bill Act (OBBBA), which potentially jeopardizes revenue stability. Despite some positive short-term operational execution, the stock's performance has lagged behind competitors in the post-acute care sector, indicating a disconnect between equity valuation and the underlying financial health and growth trajectory of the company.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares